REXFORD INDUSTRIAL REALTY, INC. (NYSE:REXR) Files An 8-K Results of Operations and Financial Condition

0

REXFORD INDUSTRIAL REALTY, INC. (NYSE:REXR) Files An 8-K Results of Operations and Financial Condition
Item 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On August1, 2017, Rexford Industrial Realty, Inc. (“Rexford Industrial”) issued a press release announcing its earnings for the quarter ended June30, 2017 and distributed certain supplemental financial information. On August1, 2017, Rexford Industrial also posted the supplemental financial information on its website located at www.rexfordindustrial.com.Copies of the press release and supplemental financial information are furnished herewith as Exhibits 99.1 and 99.2, respectively.

The information included in this Current Report on Form 8-K under this Item 2.02 (including Exhibits 99.1 and 99.2 hereto) are being “furnished” and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of the Exchange Act, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 2.02REGULATION FD DISCLOSURE

As discussed in Item 2.02 above, Rexford Industrial issued a press release announcing its earnings for the quarter ended June30, 2017 and distributed certain supplemental information.On August1, 2017, Rexford Industrial also posted the supplemental financial information on its website located at www.rexfordindustrial.com.

The information included in this Current Report on Form 8-K under this Item 2.02 (including Exhibit 99.1 and 99.2 hereto) is being “furnished” and shall not be deemed to be “filed” for the purposes of the Exchange Act, or otherwise subject to the liabilities of the Exchange Act, nor shall it be incorporated by reference into a filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The information included in this Current Report on Form 8-K under this Item 2.02 (including Exhibit 99.1 and 99.2 hereto) will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

Item 2.02FINANCIAL STATEMENTS AND EXHIBITS

(d)Exhibits.

99.1

Press Release Dated August1, 2017

99.2

Second Quarter 2017 Supplemental Financial Report


Rexford Industrial Realty, Inc. Exhibit
EX-99.1 2 rexrex991q217.htm EXHIBIT 99.1 Exhibit Exhibit 99.1  REXFORD INDUSTRIAL ANNOUNCES SECOND QUARTER 2017 FINANCIAL RESULTS- Net Income of $0.26 per Diluted Share for Second Quarter 2017 – Second Quarter 2017 Core FFO of $0.23 per Diluted Share — Same Property Portfolio NOI Up 6.6% Compared to Second Quarter 2016 – Consolidated Portfolio NOI Up 19.3% Compared to Second Quarter 2016 — Stabilized Same Property Portfolio Occupancy at 96.0% – 20.4% GAAP and 10.6% Cash Releasing Spreads -Los Angeles,…
To view the full exhibit click here

About REXFORD INDUSTRIAL REALTY, INC. (NYSE:REXR)

Rexford Industrial Realty, Inc. is a self-administered and self-managed full-service real estate investment trust (REIT). The Company is focused on owning, operating and acquiring industrial properties in Southern California infill markets. The Company’s consolidated portfolio consisted of approximately 119 properties with over 12.0 million rentable square feet. The Company also owns interest in a joint venture (the JV) that indirectly owns one property with approximately 0.5 million square feet, which it also manages. The Company manages an additional 19 properties with approximately 1.2 million rentable square feet. The Company’s properties are concentrated in various industries, such as wholesale and retail, light manufacturing, industrial equipment and components, warehousing and storage, food and beverage, business services, construction, automotive, paper and printing, pharmaceuticals and healthcare.